Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

John Williams

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
Activism Practice, capital markets, corporate
Office
Bay Area
Active in the record
2020 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPODebt Capital MarketsRegulatory & Antitrust
Sectors
Consumer & RetailHealthcare & Life SciencesTechnology
Jurisdictions
United States

Recent deals

20 announced deals in the record
Latham & Watkins Advises Codexis on US$60 Million Term Loan Facility 11 Nov 2026
Banking & Finance Healthcare & Life Sciences Latham & Watkins LLP USD 60m corporate Bay Area
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock 27 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 250m Lead corporate Bay Area
Latham & Watkins Advises IDEAYA Biosciences on US$300 Million Offering of Common Stock and Pre‑Funded Warrants 11 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 300m Lead corporate Bay Area
Latham & Watkins Represents PDF Solutions, Inc. in Upsized US$201 Million Public Offering of Common Stock 19 May 2026
Capital Markets & IPO Technology Latham & Watkins LLP USD 201m Lead corporate
Latham & Watkins Advises Ascendis Pharma on Nasdaq Ordinary Share Listing 27 Apr 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP Lead corporate Bay Area
Latham & Watkins Advises 4D Molecular Therapeutics on US$100 Million Offering of Common Stock and Pre-Funded Warrants 8 Nov 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 100m Lead corporate Bay Area
Latham & Watkins Advises Arcus Biosciences in US$250 Million Public Offering of Common Stock 4 Nov 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 250m Lead corporate Bay Area
Latham & Watkins Advises Arcus Biosciences in US$150 Million Offering of Common Stock 19 Feb 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead corporate Bay Area
Latham & Watkins Advises Revolution Medicines in Upsized US$750 Million Public Offering of Common Stock and Pre-Funded Warrants 5 Dec 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 750m Lead corporate Bay Area
Latham & Watkins Advises Ascendis Pharma in US$150 Million Royalty Financing 9 Sept 2024
Debt Capital Markets Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead transactional
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when John Williams is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 20 deals for John Williams

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction